January 29, 2019
The Pharmaceuticals and Medical Devices Agency (PMDA) said on January 28 that it has approved the use of its MID-NET medical information database by MSD for a study related to the company’s hepatitis C combo treatment Erelsa (elbasvir)/Grazyna (grazoprevir). MSD...read more